🇺🇸 FDA
Patent

US 11891402

Compositions and methods for treating cancer

granted A61KA61K38/1709A61P

Quick answer

US patent 11891402 (Compositions and methods for treating cancer) held by The Regents of the University of California expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/1709, A61P, A61P35/00, A61P35/02